drugset / Trial / NCT06244485
A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors
Non-randomizedSequentialOpen-labelTreatment
Summary
This study will evaluate the safety, tolerability, and efficacy of valemetostat tosylate in combination with DXd antibody-drug conjugates (ADC) in participants with advanced solid tumors.
Timeline
- Start
- 2024-02-22
- Primary completion
- 2028-11-01
- Completion
- 2028-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Datopotamab deruxtecan | Monoclonal antibody | — | Intravenous |
| Subject | T-DXd | Unknown | — | Intravenous |
| Subject | Valemetostat | Small molecule | — | Oral |